The relationship between I&D procedures and bacteremia remains complex. A prospective study involving afebrile adults who underwent I&D for localized cutaneous abscesses failed to detect any transient bacteremia, suggesting that systemic (arterial) seeding as a direct consequence of uncomplicated I&D is infrequent (
14). However, anorectal procedures are distinct in this regard. Due to the rich vascular supply and the presence of a mucosal barrier in the anorectal region, these procedures have been associated with transient bacteremia, as well as rare occurrences of septic emboli and liver abscesses (
15). Mucosal disruption during anorectal I&D can potentially provide a portal of entry for microorganisms into the circulation. Septic thrombophlebitis of the portal system, commonly known as pylephlebitis, is a well-recognized mechanism underlying the development of multiple hepatic abscesses following intra-abdominal infections (
16). The portal venous system, which drains blood from the gastrointestinal tract, pancreas, and spleen to the liver, can serve as a conduit for bacteria to reach the liver. A recent systematic review comprehensively summarized the etiologies, characteristic imaging hallmarks, and outcomes associated with pylephlebitis (
16). Case reports in the literature further support the existence of an anorectal-to-portal-liver pathway, with instances of pylephlebitis and pyogenic liver abscess described following anorectal interventions such as hemorrhoidal banding (
16). In our patient, the temporal relationship between perianal abscess I&D and the subsequent development of liver abscesses, the absence of any evident biliary pathology, and the presence of multifocal small hepatic lesions strongly suggest the plausibility of portal venous seeding. However, due to the lack of portal venous imaging, which could have detected pylephlebitis, and the absence of liver aspirate cultures, the exact route of infection cannot be definitively established. Future cases could benefit from the inclusion of Doppler ultrasound or contrast-enhanced CT evaluation of the portal venous system, as well as, when technically feasible, the culturing of hepatic lesions to strengthen the causal inference (
16).